Feline Calicivirus (FCV) — Management Guide for Cat Owners and Clinicians

Comprehensive guide to feline calicivirus: what it is, signs (oral ulcers, limping, VS‑FCV), diagnosis, treatment, vaccination limits and long‑term care.

Quick Overview

• What it is: Feline calicivirus (FCV) is a common RNA virus that causes upper respiratory disease, oral ulceration and occasionally more severe syndromes including a transient limping/polyarthropathy and the rare virulent systemic form (VS‑FCV).
• Who's at risk: Kittens, unvaccinated cats, multi‑cat households and shelters are at higher risk. Even vaccinated cats can be infected or become chronic shedders; some viral strains are more virulent.
• Prognosis: Most uncomplicated FCV infections are self‑limiting (days–2 weeks) with supportive care. Limbing syndrome resolves in 1–3 weeks. VS‑FCV can be severe and has a high morbidity and variable mortality in outbreaks; early intensive care improves outcome.

Pathophysiology — a simple explanation

FCV is a non‑enveloped, single‑stranded RNA virus that infects epithelial cells of the oral cavity, conjunctiva and upper respiratory tract. Viral replication causes cell death and inflammation, producing stomatitis (oral ulcers), sneezing, nasal discharge, and conjunctivitis. Some strains invade more widely, causing systemic endothelial damage, hepatic involvement and skin ulceration (VS‑FCV). The virus can also trigger immune‑mediated synovitis or direct infection of joints, producing the transient limping (polyarthritis) syndrome.

Unlike enveloped viruses, FCV is environmentally resistant — it survives longer on surfaces and requires stronger disinfectants.

Sources: Merck Veterinary Manual; Radford et al., Vet Res (2007).

Breed-, age- and environment-specific risk factors and prevalence

• Age: Kittens and young cats are more susceptible and often develop more severe clinical signs.
• Environment: Multi‑cat environments, shelters, catteries, and hospitals increase transmission risk. Close contact, fomites and people can spread virus.
• Breed: No strong breed predisposition is established. However, brachycephalic breeds may have concurrent upper airway disease that amplifies clinical signs.
• Prevalence: FCV is common worldwide. Chronic carriage rates after infection vary by population: studies report intermittent long‑term shedding in roughly 10–20% of infected cats, higher in shelters and after outbreaks (Radford et al.).

Common clinical syndromes and stages

Diagnostic approach

Goal: confirm FCV involvement, assess complications, and rule out other causes (feline herpesvirus type 1, Chlamydophila, Bordetella).

History and physical

• Vaccination history, onset of signs, environment (shelter, cattery), exposure to other sick cats
• Full exam: oral ulcers, lymphadenopathy, lung sounds, skin lesions, limb pain

• PCR of oropharyngeal/conjunctival swabs: sensitive and rapid; PCR detects viral RNA and can identify strains in outbreaks
• Virus isolation: used in reference labs
• Serology: limited usefulness—vaccination and prior exposure give positive titres, so serology cannot distinguish acute infection reliably
• CBC/Chemistry: dehydration, stress leukogram, possible thrombocytopenia or elevated liver enzymes in VS‑FCV
• Cytology/culture: if secondary bacterial infection suspected
• Joint fluid tap: in limping cats with effusion to evaluate neutrophilic inflammation

• Thoracic radiographs if coughing/respiratory distress to assess pneumonia
• Abdominal ultrasound if hepatic involvement suspected

• Severe, deteriorating or hypoxemic cats, suspected VS‑FCV, or when advanced critical care (ICU, oxygen therapy, nutritional support, feeding tube placement) or specialist diagnostics are needed — refer to a veterinary internal medicine specialist or critical care center.

Treatment — stepwise and practical

There is no specific widely‑available antiviral that reliably cures FCV. Management is supportive, symptomatic and aimed at preventing/treating secondary bacterial infections, controlling pain, and supporting nutrition and hydration. VS‑FCV requires intensive supportive and often hospital care.

General measures

• Isolation: prevent spread — strict barrier nursing, separate litter boxes, dedicated staff/clothing
• Disinfection: use bleach (1:32 household bleach solution) or accelerated hydrogen peroxide/potassium peroxymonosulfate products; allow full contact time (≈10 minutes) and follow label guidance

• Fluid therapy: IV or SC fluids to correct dehydration and maintain perfusion. In VS‑FCV, IV fluids and monitoring are often required.
• Nutritional support: encourage eating with palatable warmed food; appetite stimulants (mirtazapine 1.88–3.75 mg per cat every 48–72 h or 1.88 mg PO q48h for small cats — dose per product/clinician guidance). Place an esophagostomy feeding tube if anorexia >48–72 h to prevent hepatic lipidosis.
• Oral care: clean painful ulcers gently; topical antiseptics (0.12% chlorhexidine oral rinse) can be soothing; avoid alcohol‑based products.

• Buprenorphine (common choice): 0.01–0.03 mg/kg transmucosal (SL/PO) q8–12 h. Injectable buprenorphine or other opioids (e.g., hydromorphone 0.05–0.1 mg/kg IM/SC q4–6 h) may be used in hospital.
• NSAIDs: use cautiously and only if adequately hydrated and following vet assessment — meloxicam 0.05 mg/kg PO q24 h (dose and frequency as per vet label). Monitor renal function.

• Do not use antibiotics for simple viral infection alone. Use when secondary bacterial infection is suspected (e.g., purulent discharge, pneumonia, sepsis) or in VS‑FCV.
• Common choices: amoxicillin‑clavulanate 12.5–20 mg/kg PO q12 h; doxycycline 5 mg/kg PO q12–24 h for atypical organisms. Use culture and sensitivity if possible.

• Recombinant feline interferon‑omega (licensed in some countries, e.g., EU) has been used with variable results. Dosing follows product label and clinician judgment. Evidence is limited but may be considered in severe cases where available.
• Other antivirals (e.g., famciclovir) are aimed at herpesvirus and are not reliably effective against FCV.

• Rest, analgesia (opioids/NSAIDs as above), soft bedding.
• Joint aspiration if effusion to rule out septic arthritis and to provide diagnosis.
• Most cats recover fully within 1–3 weeks; anti‑inflammatories speed recovery.

• Intensive supportive care in hospital: IV fluids, broad‑spectrum antibiotics for secondary bacterial sepsis, analgesia, oxygen if needed, temperature control, wound care for skin ulcers, plasma transfusion if coagulopathy, nutritional support.
• Prognosis guarded to poor depending on organ involvement; early aggressive care improves survival.

• Rarely needed; debridement of necrotic skin/ulcers in VS‑FCV may be required but is generally medical management‑based.

• No proven home remedies that replace veterinary care. Some owners try topical antiseptics (chlorhexidine), supportive nutraceuticals (omega‑3 fatty acids) for chronic stomatitis, but these should be adjunctive.

Chronic carriers and infection control

• After recovery, many cats stop shedding within weeks, but a subset become chronic or intermittent shedders for months to years.
• Carriers may be clinically normal but spread virus and seed outbreaks in multi‑cat settings.
• Identification: PCR on oropharyngeal swabs can detect persistent shedding; in outbreak control, typing the virus helps identify sources.
• Management: separation of carriers, strict hygiene, vaccination of housed cats (reduces severity, not shedding), and in shelters, depopulation/re‑homing decisions may be based on risk and resources.

Vaccination: benefits and limitations

• FCV is included in core feline vaccines (FVRCP). Vaccination greatly reduces clinical disease severity and mortality but does not reliably prevent infection or the carrier state because of high genetic variability among FCV strains.
• Typical schedule: kitten series starting at 6–9 weeks, repeated every 3–4 weeks until 16 weeks of age; first booster at 1 year, then every 1–3 years based on risk assessment and guidelines (follow AAFP/WSAVA/AAHA recommendations and your veterinarian).
• Vaccine limitations: vaccine strains may not fully cross‑protect against all field strains and particularly not against emerging VS‑FCV strains. However, vaccinated cats generally have milder illness.

Long‑term management and monitoring

• For uncomplicated cases: re‑check if signs worsen or persist >10–14 days.
• For chronic stomatitis: long‑term dental care, medical therapy (antibiotics, corticosteroids, cyclosporine in refractory cases) and sometimes partial or full-mouth extractions are required to control pain and inflammation.
• For chronic shedders: periodic PCR testing if necessary for outbreak control; avoid mixing carriers with high‑risk populations.
• For cats recovering from VS‑FCV: monitor liver and kidney values, watch for secondary infections and provide ongoing wound care and nutrition.

Prognosis and quality of life

• Uncomplicated FCV: excellent to good — most cats recover with supportive care and regain normal quality of life.
• Limping syndrome: good — most recover without sequelae in weeks.
• Chronic stomatitis: guarded to fair — many cats require long‑term management; some improve dramatically after dental extractions.
• VS‑FCV: guarded to poor in many outbreaks; survivors may recover but can have sequelae (scarring, chronic oral disease). Early referral and intensive care improve survival odds.

Living With Feline Calicivirus — practical daily tips

• Isolation: keep infected cats separate from others for at least 2–3 weeks and until declared virus‑free by your vet if necessary.
• Clean carefully: use approved disinfectants (bleach 1:32 or veterinary products like accelerated H2O2), allow adequate contact time and launder bedding on hot cycle.
• Feeding: offer warm, strong‑scented wet food to stimulate appetite; hand feeding or syringe feeding may be needed short term.
• Oral care: gently clean food and water bowls, avoid sharing toys and litter boxes between infected and unexposed cats.
• Comfort: provide soft bedding, round‑the‑clock access to a litter box, and pain control as prescribed.
• Vaccination: keep household cats up to date to reduce severity.

When to See Your Vet Urgently

Seek immediate veterinary care if your cat with suspected or confirmed FCV has any of the following:

• Difficulty breathing, open‑mouth breathing, severe panting
• Marked weakness, collapse or inability to stand
• High, persistent fever (>40°C/104°F) or hypothermia
• Rapidly worsening mucosal/skin ulcers, bleeding or signs of sepsis
• Severe anorexia (>48–72 hours in adult cats) or signs of hepatic lipidosis (jaundice, anorexia, vomiting)
• Signs of shock: pale gums, very weak pulse, cold extremities

This guide is for educational purposes. Always consult your veterinarian for diagnosis and treatment.

References and further reading

• Radford AD, Coyne KP, Dawson S, Porter C, Gaskell RM. Feline calicivirus. Vet Res. 2007;38(2):319–335. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275474/
• Merck Veterinary Manual. Feline calicivirus infection. https://www.merckvetmanual.com/generalized-conditions/feline-calicivirus/feline-calicivirus-infection
• AAFP Feline Vaccination Guidelines. https://catvets.com/guidelines/practice-guidelines/vaccination-guidelines
• WSAVA Vaccination Guidelines. https://www.wsava.org/wp-content/uploads/2020/01/WSAVA-Vaccination-Guidance-2015.pdf

Frequently Asked Questions